IPP Bureau
Eris Lifesciences receives ANVISA approval at its Ahmedabad campus
By IPP Bureau - August 25, 2025
GSK forays into oncology in India with Jemperli and Zejula
By IPP Bureau - August 25, 2025
The company is bringing precision therapies for gynaecological cancers
Briefs: Mankind Pharma, Mangalam Drugs and Organics, Veerhealth Care and Shelter Pharma
By IPP Bureau - August 25, 2025
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
Akums Drugs and Pharmaceuticals signs framework agreement with Govt. of Zambia
By IPP Bureau - August 24, 2025
This project shall be implemented through incorporation of a new joint venture company in Zambia
FDA approved Dawnzera in US as first and only RNA-targeted prophylactic treatment for hereditary angioedema
By IPP Bureau - August 24, 2025
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
Corbion and Kuehnle join forces to develop natural Astaxanthin from algae fermentation
By IPP Bureau - August 23, 2025
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
Star Health Insurance settles claims of Rs.11,500 Cr
By IPP Bureau - August 23, 2025
The company has improved access to quality healthcare for seniors across both urban and rural areas
Moderna receives Health Canada approval for updated COVID-19 vaccine targeting SARS-CoV-2 Variant LP.8.1
By IPP Bureau - August 23, 2025
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
AbbVie announces positive topline results from second Phase 3 UP-AA trial evaluating Upadacitinib
By IPP Bureau - August 23, 2025
The safety profile in alopecia areata was generally consistent with that in approved indications, and no new safety signals were identified in this study
Piramal Pharma Solutions opens dedicated OSD production capabilities at Sellersville, Pennsylvania site
By IPP Bureau - August 22, 2025
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
Fortis Healthcare signs O&M agreement with Ekana Group for 550-bed hospital in Lucknow
By IPP Bureau - August 22, 2025
The facility will be positioned as a Centre of Excellence for tertiary care services
Vivo Bio Tech secures pre-clinical testing contract valued at Rs.10.75 Cr
By IPP Bureau - August 22, 2025
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
FDA lifts hold on Rocket Pharma's gene therapy trial
By IPP Bureau - August 22, 2025
Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
NATCO launches Bosentan Tablets for oral suspension in US with 180-day exclusivity
By IPP Bureau - August 21, 2025
NATCO holds the first-to-file status for this product and will have 180-day generic drug exclusivity
Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India
By IPP Bureau - August 21, 2025
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
